Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonvalvular atrial fibrillation and no history of stroke or transient ischemic attacks

被引：14

作者：

Aguilar, Maria I. ^{[1
]}

Hart, Robert ^{[2
]}

机构：

[1] Mayo Clin, Phoenix, AZ 85054 USA

[2] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA

来源：

STROKE | 2008年 / 39卷 / 04期

关键词：

anticoagulant; antiplatelet; aspirin; atrial fibrillation; stroke; warfarin;

D O I：

10.1161/STROKEAHA.107.500363

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1399 / 1400

页数：2

共 10 条

[1] Oral anticoagulants versus antiplatelet therapy for preventing stoke in patients with non-valvular artial fibrillation and no history of stroke or transient ischemic attacks
Aguilar, M., I
Hart, R.
Pearce, L. A.
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03):
[2] PREVALENCE, AGE DISTRIBUTION, AND GENDER OF PATIENTS WITH ATRIAL-FIBRILLATION - ANALYSIS AND IMPLICATIONS
FEINBERG, WM
BLACKSHEAR, JL
LAUPACIS, A
KRONMAL, R
HART, RG
[J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (05) : 469 - 473
[3] Selecting patients with atrial fibrillation for anticoagulation - Stroke risk stratification in patients taking aspirin
Gage, BF
van Walraven, C
Pearce, L
Hart, RG
Koudstaal, PJ
Petersen, P
[J]. CIRCULATION, 2004, 110 (16) : 2287 - 2292
[4] Anticoagulation therapy for stroke prevention in atrial fibrillation - How well do randomized trials translate into clinical practice?
Go, AS
Hylek, EM
Chang, YC
Phillips, KA
Henault, LE
Capra, AM
Jensvold, NG
Selby, JV
Singer, DE
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (20): : 2685 - 2692
[5] Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
Go, AS
Hylek, EM
Phillips, KA
Chang, YC
Henault, LE
Selby, JV
Singer, DE
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18): : 2370 - 2375
[6] Lessons from the Stroke Prevention in Atrial Fibrillation trials
Hart, RG
Halperin, JL
Pearce, LA
Anderson, DC
Kronmal, RA
McBride, R
Nasco, E
Sherman, DG
Talbert, RL
Marler, JR
[J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (10) : 831 - 838
[7] Hu Da-yi, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P295
[8] Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
Mant, Jonathan
Hobbs, F. D. Richard
Fletcher, Kate
Roalfe, Andrea
Fitzmaurice, David
Lip, Gregory Y. H.
Murray, Ellen
[J]. LANCET, 2007, 370 (9586) : 493 - 503
[9] A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
Rash, Amar
Downes, Tom
Portner, Robin
Yeo, Wilf W.
Morgan, Nicolette
Channer, Kevin S.
[J]. AGE AND AGEING, 2007, 36 (02) : 151 - 156
[10] Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation - An individual patient meta-analysis
van Walraven, C
Hart, RG
Singer, DE
Laupacis, A
Connolly, S
Petersen, P
Koudstaal, PJ
Chang, YC
Hellemons, B
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19): : 2441 - 2448

← 1 →